about
Intractable restless legs syndrome: role of prolonged-release oxycodone-naloxoneSleep disorders: A review of the interface between restless legs syndrome and iron metabolismAddressing sleep disturbances: an opportunity to prevent cardiometabolic disease?Treatment of restless legs syndromeEfficacy of an eight-week yoga intervention on symptoms of restless legs syndrome (RLS): a pilot study.The Effects of a Gentle Yoga Program on Sleep, Mood, and Blood Pressure in Older Women with Restless Legs Syndrome (RLS): A Preliminary Randomized Controlled Trial.Validation of the Multiple Suggested Immobilization Test: A Test for the Assessment of Severity of Restless Legs Syndrome (Willis-Ekbom Disease)Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome.Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.Efficacy of Pramipexole for the Treatment of Primary Restless Leg Syndrome: A Systematic Review and Meta-analysis of Randomized Clinical Trials.Restless legs syndrome augmentation among Japanese patients receiving pramipexole therapy: Rate and risk factors in a retrospective study.Opposing aging-related shift of excitatory dopamine D1 and inhibitory D3 receptor protein expression in striatum and spinal cordRotigotine in the Long-Term Treatment of Severe RLS with Augmentation: A Series of 28 CasesUpdate on the management of restless legs syndrome: existing and emerging treatment options.Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndromeGabapentin enacarbil for the treatment of moderate to severe primary restless legs syndrome (Willis-Ekbom disease): 600 or 1,200 mg dose?Restless legs syndrome: a review of diagnosis and management in primary care.Rotigotine transdermal system: developing continuous dopaminergic delivery to treat Parkinson's disease and restless legs syndrome.Brazilian consensus on guidelines for diagnosis and treatment for restless legs syndrome.Augmentation in restless legs syndrome patients in Korea.Augmentation of restless leg syndrome (Willis-Ekbom disease) during long-term dopaminergic treatment.A prospective study of the cumulative incidence and course of restless legs syndrome in de novo patients with Parkinson's disease during chronic dopaminergic therapy.Modulation of dopamine-dependent behaviors by the Caenorhabditis elegans Olig homolog HLH-17.Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations.Increased striatal dopamine transporter density in moderately severe old restless legs syndrome patients.Safety and efficacy of rotigotine transdermal patch in patients with restless legs syndrome: a post-hoc analysis of patients taking 1 - 3 mg/24 h for up to 5 years.
P2860
Q26766416-CFA29442-E01F-4371-9903-01BB1C15C1AFQ26781413-D799E253-7F71-4CEF-B93E-0B6148521A8EQ26861157-6BD195C4-4F80-4843-B89C-7C44BDDD0615Q27024585-134EF4AE-CF58-4980-A2A2-480F24A266AEQ30412799-297DA662-06B5-4267-9A2E-145099428720Q30427506-291FCB80-F0A6-4EE1-96F9-CB7CA522B5E3Q30540221-6A23A73F-7F74-4648-A3DC-538F6A2C6847Q33708835-6CBF80B9-1818-4A1E-ACAB-F12B660D3214Q34544928-65F9A9A7-10F3-4A0A-905E-A5AFF117705CQ35842778-18C8752B-AFAC-4BB5-AB04-EF56ECADCD6CQ36298494-7773D0F6-9ACE-4475-9449-F4A33087DE3CQ36598111-EB94EAC5-B141-4AB3-8156-A2EAF13614EEQ36635425-8960C876-48B3-46A3-8C93-B17DF88059E1Q36779828-032B70B6-4FC0-42BE-BC88-BE12B6D56E4DQ37171160-39DD1096-9C32-4104-B599-90FBDCD7932CQ37577779-8C2B4E5D-E649-4FAC-8CC8-3BCBF6463BB3Q38113094-3E2192B6-E178-42A6-A1BD-8FED9739E4AFQ38242043-9918487A-7DC3-403E-83E7-32C8A2B3B1AFQ38390415-3DF7CE97-C002-4EEE-8323-36108D703C00Q38435640-2B2758A0-1811-47CD-9813-2018325DBE39Q38528368-0EF62B8E-795A-421F-9C14-19F92C1E1F1EQ41124729-E12DB72F-B28D-40EF-8991-C7A0D20105C3Q42490242-FF7BF402-E72B-4069-AFDC-38510D7081ADQ47695915-3E96C072-35DA-4EFA-A82F-C0CE456A4ABEQ48176784-F7186A32-0730-4F0A-B396-2C8F77F5F4E6Q48205022-605C9F84-D6F1-41CB-A868-B35EA7A1BEA6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dopaminergic augmentation of restless legs syndrome.
@en
Dopaminergic augmentation of restless legs syndrome.
@nl
type
label
Dopaminergic augmentation of restless legs syndrome.
@en
Dopaminergic augmentation of restless legs syndrome.
@nl
prefLabel
Dopaminergic augmentation of restless legs syndrome.
@en
Dopaminergic augmentation of restless legs syndrome.
@nl
P1476
Dopaminergic augmentation of restless legs syndrome.
@en
P2093
Anne-Marie Williams
Diego García-Borreguero
P304
P356
10.1016/J.SMRV.2009.11.006
P577
2010-03-12T00:00:00Z